Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors

Journal of Neuro-Oncology

Volumn 119, Issue 2, 2014, Pages 343-351

  Han, Yi Peng ^a,b   Ma, Chen Kai ^a   Wang, Shen Qi ^b   Enomoto, Atsushi ^b   Zhao, Yang ^a   Takahashi, Masahide ^b   Ma, Jie ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atypical teratoid rhabdoid tumor (AT RT); Central nervous system (CNS); Medulloblastoma (MB); Osteopontin (OPN); Primitive neuroepithelial tumors (PNET); Progression

Indexed keywords

OSTEOPONTIN;

ARTICLE; CANCER PROGNOSIS; CENTRAL NERVOUS SYSTEM EMBRYONAL TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; NEUROEPITHELIOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PROTEIN EXPRESSION; RHABDOID TUMOR; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TERATOMA; TUMOR GROWTH;

EID: 84944443375     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1484-4     Document Type: Article

References (40)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system, 4th edn. IARC Press, Lyon
2. Bailey P, Cushing H (1925) Medulloblastoma cerebelli, a common type of midcerebellar glioma of childhood. Arch Neurol Psychiatry 14:192-224
3. Adesina AM, Hunter J (2010) Medulloblastoma. In: Tihan T, Fuller CE, Poussaint TY (eds) Atlas of pediatric brain tumors, 1st edn. Springer, New York, p 75
4. Pomeroy SL, Tamayo P, Gaasenbeek M et al (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436-442 (Pubitemid 34100955)
5. Gilbertson RJ, Ellison DW (2008) The origins of medulloblastoma subtypes. Annu Rev Pathol 3:341-365 (Pubitemid 351488285)
6. Lefkowity IB, Rorke LB, Packer RJ et al (1987) Atypical teratoid tumor of infancy: definition of an entity. Ann Neurol 22:448-449
7. Helseth E, Due-Tonnessen B, Wesenberg F et al (1999) Posterior fossa medulloblastoma in children and young adults (0-19 years): survival and performance. Childs Nerv Syst 15:451-455
8. Geyer JR, Sposto R, Jennings M et al (2005) Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the children's cancer group. J Clin Oncol 23:7621-7631 (Pubitemid 46291826)
9. Chintagumpala M, Hassall T, Palmer S et al (2009) A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET. Neuro Oncol 11:33-40
10. Athale UH, Duckworth J, Odame I et al (2009) Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies. J Pediatr Hematol Oncol 31:651-663
11. Parwani AV, Stelow EB, Pambuccian SE et al (2005) Atypical teratoid/rhabdoid tumor of the brain: cytopathologic characteristics and differential diagnosis. Cancer 105:65-70 (Pubitemid 40604939)
12. Bishop JA, Ali SZ (2012) Pediatric atypical teratoid/rhabdoid tumors: differential diagnosis. In: Hayat MA (ed) Pediatric cancer, volume 2: teratoid/rhabdoid, brain tumors, and glioma, 2012th edn. Springer, Dordrecht, pp 53-56
13. Biegel JA, Tan L, Zhang F et al (2002) Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8:3461-3467 (Pubitemid 35340722)
14. Biegel JA, Kalpana G, Kundsen ES et al (2002) The role of INI and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Res 62:323-328 (Pubitemid 34074022)
15. Oldberg A, Franzén A, Heinegård D (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 83:8819-8823 (Pubitemid 17223492)
16. Konno S, Kurokawa M, Uede T et al (2011) Role of osteopontin, a multifunctional protein, in allergy and asthma. Clin Exp Allergy 41:1360-1366
17. Chen G, Zhang X, Li R et al (2010) Role of osteopontin in synovial Th17 differentiation in rheumatoid arthritis. Arthritis Rheumatol 62:2900-2908
18. Carecchio M, Comi C (2011) The role of osteopontin in neurodegenerative diseases. J Alzheimers Dis 25:179-185
19. Ahmed M, Behera R, Chakraborty G et al (2011) Osteopontin: a potentially important therapeutic target in cancer. Expert Opin Ther Targets 15:1113-1126
20. Shevde LA, Das S, Clark DW et al (2010) Osteopontin: an effector and an effect of tumor metastasis. Curr Mol Med 10:71-81
21. Weber GF, Lett GS, Haubein NC (2010) Osteopontin is a marker for cancer aggressiveness and patient survival. Br J Cancer 103:861-869
22. Kao CL, Chiou SH, Chen YJ et al (2005) Increased expression of osteopontin gene in atypical teratoid/rhabdoid tumor of the central nervous system. Mod Pathol 18:769-778
23. Kao CL, Chiou SH, Ho DMT et al (2005) Elevation of plasma and cerebrospinal fluid osteopontin levels in patients with atypical teratoid/rhabdoid tumor. Am J Clin Pathol 123:297-304
24. Bruggers CS, Bleyl SB, Pysher T et al (2011) Clinicopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system. Pediatr Blood Cancer 56:1026-1031
25. Fromowitz FB, Viola MV, Chao S et al (1987) Ras p21 expression in the progression of breast cancer. Hum Pathol 18:1268-1275 (Pubitemid 18018958)
26. Iwanaga Y, Ueno M, Ueki M et al (2008) The expression of osteopontin is increased in vessels with blood-brain barrier impairment. Neuropathol Appl Neurobiol 34:145-154 (Pubitemid 351327956)
27. Selkirk SM, Morrow J, Barone TA et al (2008) Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersal. J Neurooncol 86:285-296
28. Toy H, Yavas O, Eren O et al (2009) Correlation between osteopontin protein expression and histological grade of astrocytomas. Pathol Oncol Res 15:203-207
29. Matusan-Ilijas K, Behrem S, Jonjic N et al (2008) Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma. Pathol Oncol Res 14:293-298
30. Woehrer A, Slavic I, Waldhoer T et al (2010) Incidence of atypical teratoid/rhabdoid tumors in children: a population-based study by the austrian brain tumor registry, 1996-2006. Cancer 116:5725-5732
31. Hollmann TJ, Hornick JL (2011) INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol 35:e47-e63
32. Judkins AR, Burger PC, Hamilton RL et al (2005) INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J Neuropathol Exp Neurol 64:391-397 (Pubitemid 40629129)
33. Hasselblatt M, Gesk S, Oyen F et al (2011) Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Am J Surg Pathol 35:933-935
34. Ma HI, Kao CL, Lee YY et al (2010) Differential expression profiling between atypical teratoid/rhabdoid and medulloblastoma tumor in vitro and in vivo using microarray analysis. Childs Nerv Syst 26:293-303
35. Chakraborty G, Jain S, Kundu GC (2008) Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res 68:152-161 (Pubitemid 351380116)
36. Jan HJ, Lee CC, Shih YL et al (2010) Osteopontin regulates human glioma cell invasiveness and tumor growth in mice. Neuro Oncol 12:58-70
37. Arikök AT, Onder E, Seçkin H et al (2013) Osteopontin expressions correlate with WHO grades and predict recurrence in meningiomas. Brain Tumor Pathol. doi:10.1007/s10014-013-0152-2
38. Lin CK, Tsai WC, Lin YC, Hueng DY (2012) Osteopontin predicts the behaviour of atypical meningioma. Histopathology 60:320-325
39. Tsai WC, Lee HS, Lin CK et al (2012) The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas. Histopathology 61:844-856
40. Barresi V, Caffo M, Ieni A et al (2011) Osteoblastic meningiomas: clinico-pathological and immunohistochemical features of an uncommon variant. J Neurooncol 105:225-232